{
    "code": 0,
    "data": [
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation of Financial Results as on 31st December 2025",
            "news_id": "3e6488ed-c234-4f29-8c77-21dc2815e6d7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=192222ad-bc7b-46e3-9a0a-49b54095fd81.pdf",
            "news_date": "2026-01-31 19:41:45",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "Financial Results as on 31st December 2025.",
            "news_id": "e15c1024-cd84-4f10-bc8d-54ffaa88b35e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a6e8bd59-da99-4715-a755-4b13de1cc32a.pdf",
            "news_date": "2026-01-31 15:59:39",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earning Call Transcript",
            "news_id": "c3cf59f4-1e78-49a6-8422-1bfccb5d644e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e0665acc-bf43-47b6-8ad1-be7500909784.pdf",
            "news_date": "2025-11-18 17:16:11",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on financial results as on 30th September 2025.",
            "news_id": "a8c50ddf-ab0f-4525-95a9-816d9cae49e5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b71106d-3520-4e8a-a096-586f91bbdee6.pdf",
            "news_date": "2025-11-14 10:32:44",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results As On 30Th September 2025",
            "news_body": "Outcome of Board Meeting",
            "news_id": "4212a0a8-cc98-450b-afc2-e5e775134442",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9b160e1-c286-4073-bab5-3edbf5f2e132.pdf",
            "news_date": "2025-11-13 18:08:11",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on financial results as on 30th June 2025",
            "news_id": "d222a32f-40e1-4e47-8160-7aaab56a8457",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bcd6f28d-7fd0-46e4-8e91-7a24921e6346.pdf",
            "news_date": "2025-07-11 17:11:39",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results As On 30Th June 2025.",
            "news_body": "The Board of Directors of the Company at Meeting held today on 11th July 2025 has approved the following\r\n\r\n1. Stanaldone and Consolidated Financial Results as on 30th June 2025.\r\n\r\n2. Appointment of Ms. Payal Jain as Additional Director (Independent) of the Company.",
            "news_id": "71e28751-a625-494d-919c-0fef00989903",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d939bbdd-7d77-48c2-832d-9f0a982c8cd2.pdf",
            "news_date": "2025-07-11 16:44:53",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earning call held on 30th April 2025",
            "news_id": "b3340bc6-2dde-45b6-9281-5c596e486d6c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dc494e73-2aa0-458c-989b-3eac83338a68.pdf",
            "news_date": "2025-05-02 16:32:59",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Audited Financial Results as on 31st March 2025",
            "news_id": "4de9af20-d95f-418c-8899-1787894d9eab",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9e53f526-d9c4-4959-aead-af1a06a071d2.pdf",
            "news_date": "2025-04-29 18:02:48",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results As On 31St March 2025",
            "news_body": "The Board in the meeting held today on 29th April 2025 has approved the Standalone and Consolidated Financial Results as on 31st Match 2025.",
            "news_id": "8187b57c-7a38-46e4-ad45-5d69b447d7d0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07c82f86-ba38-4f7e-95bb-ebd92fa7732d.pdf",
            "news_date": "2025-04-29 17:48:03",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on financial results for 31st December 2024.",
            "news_id": "a403ba6a-b52c-469d-9003-63c3272c0160",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7cfe9bbf-e808-4dd4-aeef-9a8cf92fd2e3.pdf",
            "news_date": "2025-01-25 20:29:34",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome of Board Meeting",
            "news_body": "Nath Bio-Genes (India) Ltd has informed BSE regarding Outcome of Board Meeting held on January 23 2025.",
            "news_id": "b8d5561b-1703-4e09-ad79-841cd079e603",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=813CC6BA-E627-45AB-BE90-66B138B02B3B-170502.pdf",
            "news_date": "2025-01-23 17:05:06",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference call held on 24th October 2024.",
            "news_id": "8b1e94fb-a4bd-4bff-9684-a1075247da39",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=846f5ad3-7416-4e0c-a6c6-03c43c762c71.pdf",
            "news_date": "2024-10-28 19:10:07",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Audio Transcript of Earning Call held on 24th October 2024",
            "news_id": "1b64b54f-1f94-4ebc-b659-4b3fc06c0638",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=554ed23a-62ca-423a-beb6-9718a73512d7.pdf",
            "news_date": "2024-10-25 17:32:13",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation on Unaudited financial results as on 30th Sept 2024.",
            "news_id": "88556116-4bf7-4470-a03c-5ca6767340b1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0fda3214-99d1-43a1-98ef-61bd83debb58.pdf",
            "news_date": "2024-10-23 17:34:07",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results As On 30Th Sept 2024",
            "news_body": "Outcome of Board Meeting",
            "news_id": "f56ef942-1e4d-4697-8a67-f19829da8875",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6086d580-4cc8-470a-99c6-460067cee4b7.pdf",
            "news_date": "2024-10-23 16:31:07",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation on Unaudited Financial results as on 30th June 2024",
            "news_id": "4c5d7a42-fa43-4ea5-971c-530ebf96d6e8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5666baaa-6018-49fc-8dc3-aa6f07e67334.pdf",
            "news_date": "2024-08-07 22:13:21",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results As On 30Th June 2024",
            "news_body": "Outcome of Board Meeting",
            "news_id": "af2bf93a-71f0-403e-be2d-ea59688a304a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=66770976-1c09-4201-b875-50ecb11a2959.pdf",
            "news_date": "2024-08-07 15:48:38",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call transcript held on 09th May 2024",
            "news_id": "95c36dec-c33b-413d-8fa5-82bbec0f15af",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0b7a82c-d506-4780-ba7c-b714e9a6a677.pdf",
            "news_date": "2024-05-14 14:56:46",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Audio Recording Of Conference Call",
            "news_body": "Audio Recording of Conference call held on 09th May 2024 at 04:00 PM on Audited Financial Results of the Company.",
            "news_id": "01515bbc-f004-4094-84b2-db7f4b84487d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0dd2617-c442-4ea3-94a7-b5b5683877e4.pdf",
            "news_date": "2024-05-09 20:07:55",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Audited Financial Results as on 31st March 2024.",
            "news_id": "b53cc7d5-328b-4114-a3c9-49c8519635ad",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=23ea2acb-d43e-43cf-8de1-47ab587d1b9e.pdf",
            "news_date": "2024-05-08 17:29:14",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results As At 31St March 2024",
            "news_body": "Outcome of Board Meeting of the Company held on 08th May 2024.",
            "news_id": "517b29f5-8f12-443d-ae46-5a47fa275ff6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e74e136-b51e-4adc-9001-dcb82616033b.pdf",
            "news_date": "2024-05-08 17:19:41",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the financial results as on 31st December 2023.",
            "news_id": "2b56fade-ae4a-4b8f-8205-6921c809d5f9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=299b2362-6a89-4d5d-bb77-d9a13c147809.pdf",
            "news_date": "2024-01-18 18:45:46",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "The Outcome Of The Meeting Of The Board Of Directors Of The Company Held On 31St December 2023.",
            "news_body": "Outcome of Board Meeting",
            "news_id": "a47f9746-e541-4b06-8a4b-1f3ac113433e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a7cc754-12dc-4d79-8397-d04766a0e3fa.pdf",
            "news_date": "2024-01-18 18:27:29",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference Call held on 17th October 2023",
            "news_id": "5079a103-0c55-4026-96ea-15fd62d1a32b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=25037e02-130e-4117-ab1c-7d1be723699c.pdf",
            "news_date": "2023-10-21 10:00:00",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation on Unaudited financial results as of 30th Sept 2023",
            "news_id": "ff4b6200-b8bf-4067-bd40-7e42483a5ade",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d2cc706-307e-402b-99d0-c138b6100578.pdf",
            "news_date": "2023-10-16 18:21:20",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results As Of 30Th Sept 2023",
            "news_body": "Unaudited financial results as of 30th Sept 2023",
            "news_id": "310807ac-cb47-4368-b195-f603923019d5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af0c0cb8-8256-4d7c-8e3e-44115ab78972.pdf",
            "news_date": "2023-10-16 18:09:21",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Financial Results as of 30th June 2023",
            "news_id": "2af4288b-e5e7-4686-924d-be7aa01e3222",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cfb2c7f5-f88c-49a1-9201-d8649a222511.pdf",
            "news_date": "2023-08-10 20:33:51",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results As Of 30Th June 2023",
            "news_body": "Unaudited quarterly Standalone and Consolidated financial results as on 30th June 2023.",
            "news_id": "4846e2ae-01bf-4394-9828-de86e7454f19",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3bc6f758-b0a7-4ff6-8d35-3a0d1886f357.pdf",
            "news_date": "2023-08-10 17:41:53",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earning Call Transcript",
            "news_id": "9bd1da52-145e-444d-99f2-c5cb1dbf1aaf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1f2e330e-cdde-4014-b642-3d686352636c.pdf",
            "news_date": "2023-04-27 15:02:07",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Audited Financial Results as of 31st March 2023.",
            "news_id": "e69b320b-5541-4eac-91ff-85767f9a44f9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=238b954b-cc30-4b88-be90-958522ac64b2.pdf",
            "news_date": "2023-04-22 18:24:41",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results As Of 31St March 2023",
            "news_body": "Audited Financial Results as of 31st March 2023",
            "news_id": "5e7e832d-1954-4762-b5d2-0e264c66a97c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d54addc5-8efa-4a9a-9dd9-cdae824a2e1c.pdf",
            "news_date": "2023-04-22 17:58:25",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation on Unaudited financial results as on 31st December 2022.",
            "news_id": "570698bc-6519-4e87-9e85-d01686dd20a0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bee73321-6baa-43b5-870c-9f54b7549ccb.pdf",
            "news_date": "2023-02-14 17:17:26",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results As On 31St December 2022.",
            "news_body": "Unaudited Financial Results as on 31st December 2022.",
            "news_id": "c7bd272f-6457-4daf-bf5c-db28ff2853b5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f42e4178-cd22-40d5-a75b-b0afe2f1fcbc.pdf",
            "news_date": "2023-02-14 16:28:24",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Under Reg 23 (9).",
            "news_body": "Disclosure of Related Party Transactions under Reg 23 (9).",
            "news_id": "21a8a2a5-48e7-4881-a920-7fe0ea864756",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a51ac556-0335-41b8-978e-13e73f5149d2.pdf",
            "news_date": "2022-11-03 17:54:18",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on financial results as on 30.09.2022.",
            "news_id": "e009c36d-e2ca-4921-b036-d357ac1caaf7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b4f8bc66-0568-46dc-a579-bb202c18dbeb.pdf",
            "news_date": "2022-10-20 17:07:15",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited Financial Results As On 30.09.2022",
            "news_body": "Unaudited Financial Results as on 30.09.2022",
            "news_id": "108bfa93-5bb7-4eb6-a69b-687ebd5191a2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e735784-4a7c-4266-af95-bb29e5e86565.pdf",
            "news_date": "2022-10-20 15:43:21",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results As On 30.09.2022",
            "news_body": "Financial Results as on 30.09.2022",
            "news_id": "111b7b45-4620-4d5f-b278-25ebdeda356b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5094955e-9ff5-4601-99be-801e28f320e6.pdf",
            "news_date": "2022-10-20 15:41:18",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the quarter ended on 30th June 2022",
            "news_id": "083f418c-d8c3-4e72-80cd-825ae6fe4a6b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb767893-e923-4913-b771-94cc100368f8.pdf",
            "news_date": "2022-08-13 18:46:46",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results As On 30Th June 2022",
            "news_body": "Financial Results as on 30th June 2022",
            "news_id": "57a75981-ba1d-470f-a911-8b6b99788660",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=730e3bb8-3805-4e7b-b6eb-07376fb92dc7.pdf",
            "news_date": "2022-08-13 16:41:49",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Under Regulation 23 (9) On Related Party Transaction For The Half-Year Ended 31St March 2022.",
            "news_body": "Disclosure under Regulation 23 (9) on Related Party Transaction for the half-year ended 31st March 2022.",
            "news_id": "10142060-0f4e-49b1-8c11-ab4f94e42d94",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=613062c1-bc2c-448d-b39f-0e08d9817dbf.pdf",
            "news_date": "2022-06-11 16:36:54",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference call with the Investors/Analysts",
            "news_id": "bbafe5a7-a1df-46d9-b0a9-c532d5d93b1d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a408b07-3366-4348-bba1-aee9f6596845.pdf",
            "news_date": "2022-06-02 11:26:58",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation on Audited FInancial Results as on 31st March 2022.",
            "news_id": "e624ff83-9187-43da-a4e2-95f4922747d0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=645dc102-ab67-46e4-95c9-0340026cfbc6.pdf",
            "news_date": "2022-05-30 16:46:45",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for The Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting held on 30th May 2022.",
            "news_id": "cd1c1958-a992-4d2b-8cae-1258755d4bfb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=718de040-28da-40ea-bd49-24bb557a3b9e.pdf",
            "news_date": "2022-05-30 16:18:48",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results As On 31St March 2022",
            "news_body": "Audited Financial Results as on 31st March 2022",
            "news_id": "d968508f-fa04-49b2-b305-7b1b1a39bb90",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec39a129-35e6-4b8a-ad10-16bbb1728f72.pdf",
            "news_date": "2022-05-30 16:15:34",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation on unaudited financial results as on 31st December 2021",
            "news_id": "a84e283e-d8e8-4b3a-919d-5458a51880f1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2af4ac37-c5e7-41d9-b91b-53cd91273bdd.pdf",
            "news_date": "2022-02-14 18:30:46",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Financial Results As On 31St December 2021.",
            "news_body": "Financial Results as on 31st December 2021.",
            "news_id": "4287252d-b1da-4363-a6e5-87a2228103e4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da9bb935-d14a-42ec-b119-56754343bf06.pdf",
            "news_date": "2022-02-11 16:19:14",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results As On 31St December 2021",
            "news_body": "Financial Results as on 31st December 2021.",
            "news_id": "01265ae7-11e4-4996-95a4-68e1b279bc78",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=44f69550-a323-4f25-8adc-89fcd550b827.pdf",
            "news_date": "2022-02-11 16:17:37",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference Call held on 02/11/2021",
            "news_id": "f063f71d-8b3f-4943-a650-5dde6620521e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73656d78-e895-4816-ba93-56a3e804edb3.pdf",
            "news_date": "2021-11-08 16:04:55",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation of financial results as on 30.09.2021",
            "news_id": "313e00dd-57e5-4fef-98d4-614db878beba",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fd3bcb75-98f5-46ee-8534-5e2bb6037b93.pdf",
            "news_date": "2021-11-01 16:51:04",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Financial Results For The Period Ended 30Th Sept 2021",
            "news_body": "Financial Results for the period ended 30th Sept 2021",
            "news_id": "d0045b5a-1ef9-4801-9886-0e86a1748ed0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5dac2aaf-23cb-4bc5-ab87-bb50407488f8.pdf",
            "news_date": "2021-11-01 16:26:09",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Period Ended 30Th Sept 2021",
            "news_body": "Financial Results for the period ended 30th Sept 2021",
            "news_id": "abcd7548-c4dd-43bd-928e-d174498402dd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3178fdee-97ab-42aa-a7d1-1465c2028f50.pdf",
            "news_date": "2021-11-01 16:24:35",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earning Call Transcript",
            "news_id": "315a2cf5-025a-4ef3-964d-c600cbdc02ab",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac9e9595-d649-4384-afc0-6a491af2ff28.pdf",
            "news_date": "2021-08-17 17:18:44",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation on Unaudited financial results as on 30th June 2021",
            "news_id": "29ef3045-431f-48f5-9cb6-156eaeead436",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d79807a8-3738-4331-b2c9-71928fddc949.pdf",
            "news_date": "2021-08-10 18:34:45",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results As On 30Th June 2021",
            "news_body": "Financial Results as on 30th June 2021",
            "news_id": "dcc78a06-76b2-4e00-844c-52733607d19d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d21a28f1-f188-4c6f-9888-d5f92babdf43.pdf",
            "news_date": "2021-08-10 17:11:51",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transaction Under Regulation 23(9) Of SEBI (Listing Obligation And Disclosure Requirement)Regulation 2015.",
            "news_body": "Disclosure of Related Party Transaction under regulation 23(9) of SEBI (Listing Obligation and Disclosure Requirement)Regulation 2015.",
            "news_id": "eaa22ea3-cddb-4ec8-83f8-77ac4d2e05b9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5d8d3fdf-0456-4a22-97c1-68577ec38639.pdf",
            "news_date": "2021-07-22 12:12:05",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Conference Call held on 25th June 2021.",
            "news_id": "99df137f-a195-4a88-ac75-3faa65a0b118",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=763ccb17-e470-442b-a812-6447510be3c9.pdf",
            "news_date": "2021-07-01 13:11:17",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Audited Financial Results as on 31st March 2021.",
            "news_id": "bebb5c3e-8263-4ece-b4c6-e506a6dc896e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec165a70-fbd5-41c9-ba15-780d6217e3d4.pdf",
            "news_date": "2021-06-24 16:58:01",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results As On 31St March 2021",
            "news_body": "Audited Financial Results as on 31st March 2021",
            "news_id": "48e41849-d1f0-4f4c-b731-7ee1da5bece0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=128c086b-d117-4795-befc-fb1496433375.pdf",
            "news_date": "2021-06-24 16:22:47",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "NATHBIOGEN",
            "disp": "Nath Bio-Genes",
            "bse_code": 537291,
            "isin": "INE448G01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Con Call held on 12th February 2021",
            "news_id": "84214e99-c94c-497b-9c6f-8abdbc60b238",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef8bee27-e345-4268-8b6e-714875a57ce2.pdf",
            "news_date": "2021-02-17 16:20:58",
            "seo": "nath-bio-genes-ltd",
            "ltp": 148.75,
            "ch": -4.990000000000009,
            "pch": -3.24573956029661,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 11065,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}